-

Milliman analysis: Multiemployer pensions approach 100% funding in aggregate at year-end 2024

Market gains and SFA funding shave $64 billion from combined funding shortfall

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the 2024 year-end results of its Multiemployer Pension Funding Study (MPFS), which analyzes the funded status of all U.S. multiemployer defined benefit pension plans based on assumptions and data in their latest Form 5500 filings.

As of December 31, 2024, Milliman estimates that the aggregate funded percentage of all multiemployer plans hit 97%, up from 89% a year prior. The rise is largely due to investment gains – estimated at 10% based on our assumed portfolio – and special financial assistance (SFA) under the American Rescue Plan Act. As of year-end 2024, 102 plans have received nearly $70 billion in SFA funding, including $16 billion paid during 2024. Without SFA, the MPFS plans’ aggregate funded percentage at year-end 2024 would be approximately 89%.

Examining the plans’ funding more closely, 53% (627 of 1,193 plans) are 100% funded or more, and 84% (1,005) are 80% funded or better. On the other end, 7% of plans (85) are below 60% funded and may be headed toward insolvency. Many are likely eligible and expected to apply for SFA in 2025.

“Strong returns during the first and third quarters of 2024 largely drove the year’s significant rise in the aggregate funded percentage, which reached the second-highest point since Milliman launched this study in 2007,” said Tim Connor, MPFS co-author. “We now see more than half of all plans funded 100% or better as they continue their trend of upward improvement in funded percentage.”

View the year-end MPFS or read Milliman’s full range of Pension Funding Studies. To receive regular updates of Milliman’s pension funding analysis, contact us at pensionfunding@milliman.com.

About Milliman

Milliman leverages deep expertise, actuarial rigor, and advanced technology to develop solutions for a world at risk. We help clients in the public and private sectors navigate urgent, complex challenges—from extreme weather and market volatility to financial insecurity and rising health costs—so they can meet their business, financial, and social objectives. Our solutions encompass insurance, financial services, healthcare, life sciences, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

Contacts

Tim Connor
Milliman, Inc.
Tel: 973.569.5609
timothy.connor@milliman.com

Milliman


Release Summary
Milliman has just released its latest Multiemployer Pension Funding Study.
Release Versions

Contacts

Tim Connor
Milliman, Inc.
Tel: 973.569.5609
timothy.connor@milliman.com

More News From Milliman

Milliman analysis: Corporate pension funding levels rise for eighth consecutive month in November

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans. During November, the PFI funded ratio edged up from 107.0% at the end of October to 107.1% as of November 30. A 1-basis-point rise in discount rates, to 5.34% in November, drove this result. It shaved $3 billion from plan liabilities and offset market returns of only 0.44%. As o...

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...
Back to Newsroom